Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-04-19 4:31 pm Purchase | 13D | T2 BIOSYSTEMS INC PAR $0.0 TTOO | CR Group L.P. | 4,104,838 46.68% | 4,104,838 (New Position) | View |
2024-03-11 6:14 pm Purchase | 13G | T2 BIOSYSTEMS INC PAR $0.0 TTOO | Safier Jacob | 350,000 7.1% | 350,000 (New Position) | View |
2024-03-11 6:11 pm Purchase | 13G | T2 BIOSYSTEMS INC PAR $0.0 TTOO | New Dimensions Trading | 350,000 7.1% | 350,000 (New Position) | View |
2024-02-13 8:15 pm Purchase | 13G | T2 BIOSYSTEMS INC PAR $0.0 TTOO | Lind Global Fund II LP | 20,370 0.5% | 20,370 (New Position) | View |
2023-07-31 07:11 am Purchase | 13G | T2 BIOSYSTEMS INC TTOO | GSA CAPITAL PARTNERS LLP | 4,599,059 1.5% | 799,572 (+21.04%) | View |
2023-07-13 3:58 pm Purchase | 13G | T2 BIOSYSTEMS INC TTOO | CR Group L.P. | 72,503,592 19.9% | 72,503,592 (New Position) | View |
2023-06-30 07:09 am Sale | 13G | T2 BIOSYSTEMS INC TTOO | GSA CAPITAL PARTNERS LLP | 3,799,487 15.2% | -21,088,235 (-84.73%) | View |
2023-06-22 6:51 pm Purchase | 13G | T2 BIOSYSTEMS INC TTOO | Carrick Jason | 2,000,000 8% | 2,000,000 (New Position) | View |
2023-06-22 10:50 am Sale | 13G | T2 BIOSYSTEMS INC TTOO | Markey John | 0 0% | -4,300,000 (Position Closed) | View |
2023-06-21 12:59 pm Purchase | 13G | T2 BIOSYSTEMS INC TTOO | GSA CAPITAL PARTNERS LLP | 24,887,722 10.7% | 24,887,722 (New Position) | View |
2023-06-16 07:00 am Purchase | 13G | T2 BIOSYSTEMS INC TTOO | Markey John | 4,300,000 17.3% | 650,000 (+17.81%) | View |
2023-06-14 07:00 am Purchase | 13G | T2 BIOSYSTEMS INC TTOO | Markey John | 3,650,000 14.7% | 1,185,000 (+48.07%) | View |
2023-06-12 09:22 am Purchase | 13G | T2 BIOSYSTEMS INC TTOO | Markey John | 2,465,000 9.9% | 2,465,000 (New Position) | View |
2023-02-21 4:51 pm Purchase | 13G | T2 BIOSYSTEMS INC TTOO | Lind Global Fund II LP | 1,018,518 6.2% | 1,018,518 (New Position) | View |
2021-02-16 3:37 pm Purchase | 13G | T2 BIOSYSTEMS INC TTOO | GOLDMAN SACHS & CO. LLC | 4,358,868 3% | 4,358,868 (New Position) | View |
2020-02-12 2:49 pm Purchase | 13G | T2 BIOSYSTEMS INC TTOO | GOLDMAN SACHS GROUP INC GS | 4,324,629 9.3% | 35,289 (+0.82%) | View |
2020-02-07 4:13 pm Sale | 13G | T2 BIOSYSTEMS INC TTOO | Senvest Management LLC | 0 0% | -2,831,973 (Position Closed) | View |